A Randomized, Double-Blind, Placebo-Controlled, First-Time-in-Human Study to Assess the Safety, Tolerability, and Pharmacokinetics of Single and Multiple Ascending Doses of GSK3389404 in Healthy Subjects.
Clin Pharmacol Drug Dev
; 8(6): 790-801, 2019 08.
Article
in En
| MEDLINE
| ID: mdl-30861337
Key words
Full text:
1
Database:
MEDLINE
Main subject:
Oligonucleotides, Antisense
Type of study:
Clinical_trials
/
Prognostic_studies
Limits:
Adult
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Clin Pharmacol Drug Dev
Year:
2019
Type:
Article
Affiliation country:
United States